Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -6.06 | N/A |
PEG Ratio (TTM) | 0.72 | N/A |
P/S Ratio (TTM) | 0.60 | N/A |
P/B Ratio (TTM) | 0.34 | N/A |
P/FCF Ratio (TTM) | -7.82 | N/A |
Price to 5YR AVG Earnings Ratio | -13.42 | N/A |
Price to 5YR AVG FCF Ratio | -3.01 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -4.56% | N/A |
ROE (TTM) | -5.25% | N/A |
Net Profit Margin (TTM) | -9.84% | N/A |
ROIC 5YR AVG | -0.09% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -26.71% | 8,037.92% | 4,831.51% |
Revenue | 44.94% | 36.28% | 19.18% |
Net Income | -17.26% | 9,097.42% | 5,475.09% |
Cash Flow | 35.05% | -738.34% | -411.29% |
Health (51%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.33 | N/A |
Quick Ratio (TTM) | 6.33 | N/A |
D/E Ratio (TTM) | 0.09 | N/A |
Interest Coverage (TTM) | -2.39 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 1.49 | N/A |
LTL to 5YR AVG FCF | -1.04 | N/A |
Shares Outstanding Growth 5YR AVG | 6.66% | N/A |